Eli Lilly and Co
XHAM:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XHAM:LLY
|
US |
|
Genfit SA
NASDAQ:GNFT
|
FR |
|
Armlogi Holding Corp
NASDAQ:BTOC
|
US |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
Backblaze Inc
NASDAQ:BLZE
|
US |
|
A
|
Archean Chemical Industries Ltd
NSE:ACI
|
IN |
|
22nd Century Group Inc
NASDAQ:XXII
|
US |
|
B
|
BRP Inc
NASDAQ:DOOO
|
CA |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 050.82 EUR with a low forecast of 735.81 EUR and a high forecast of 1 349.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 050.82
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 050.82 EUR with a low forecast of 735.81 EUR and a high forecast of 1 349.9 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 18%.
